Safety of a novel oral single-agent fumarate, BG00012, in patients with relapsing-remitting multiple sclerosis: results of a phase 2 study


Gold R., Havrdova E., Kappos L., Limmroth V., Miller D., Polman C., ...More

16th Annual Meeting of the European-Neurological-Society, Lausanne, Switzerland, 27 - 31 May 2006, vol.253, pp.144-145 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 253
  • City: Lausanne
  • Country: Switzerland
  • Page Numbers: pp.144-145